Evaluation of intra- and transretinal blood flow in Retinal Angiomatous Proliferation detected with phase-resolved Optical Coherence Tomography before and after treatment

Evaluation of intra- and transretinal blood flow in Retinal Angiomatous Proliferation detected with phase-resolved Optical Coherence Tomography before and after treatment - RAP treatment evaluated with Doppler OCT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45004

Enrollment

Registered

2014-05-26

Start date

2016-09-16

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RAP

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age * 60 years Diagnosis of RAP based on fundus photography, FA and/or ICG The study eye has not been treated for exudative ARMD for at least one year (i.e. no treatment with anti-VEGF, periocular steroids or laser in the study eye within the last year). The specific RAP location has to be treatment-naïve for laser Informed consent

Exclusion criteria

Exclusion criteria: Ocular surgery within the last 3 months, with the exception of uncomplicated cataract surgery. Participation in another ophthalmic trial requiring follow-up examinations or using an investigational drug within the last 12 weeks Other active ocular diseases which irreversibly compromise or, during follow-up, are likely to compromise visual acuity or good visualization of the study eye including ocular surgery scheduled within 3 months after start of the study

Design outcomes

Primary

Measure	Time frame
Structural changes and intra-/transretinal blood flow.	—

Secondary

Measure	Time frame
visual acuity fundusphotography FA/ICG SD-OCT	—

Countries

Netherlands

Outcome results